Watford General Hospital is a 521-bed acute District General Hospital situated on Vicarage Road, Watford, Hertfordshire. Together with Hemel Hempstead Hospital and St Albans City Hospital, it is operated by West Hertfordshire Hospitals NHS Trust.

There are 521 beds in Watford General Hospital.

During the past decade, Watford General Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Watford General Hospital" #1 sponsor was "University of Southampton" with 2 trials, followed by "Children's Cancer and Leukaemia Group" with 1 trials sponsored, "Revimmune" with 1 trials sponsored, "Royal Brompton & Harefield NHS Foundation Trust" with 1 trials sponsored and "Royal Liverpool University Hospital" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Watford General Hospital" #1 collaborator was "West Hertfordshire Hospitals NHS Trust" with 3 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator, "Amarex Clinical Research" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Watford General Hospital" are "COVID-19" (4 trials), "Anastomotic Leak" (1 trials), "Anxiety" (1 trials), "Breast Cancer Female" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Watford General Hospital" in a lesser frequency.

Most popular intervention types in "Watford General Hospital" are "Drug" (6 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Watford General Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Watford General Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Watford General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Watford General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".